All In MedTech

Device Trial Radar · NCT06352684

Effectiveness of CadAI-B for Breast

Multi-Reader Multi-Case, Retrospective Study to Evaluate Effectiveness of CadAI-B for Breast

Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,000

Actual

Start

Nov 24, 2023

Primary completion

Jul 1, 2024

Study completion Aug 21, 2025

Sponsor

Lead sponsor
BeamWorks Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Severance Hospital
First posted
Apr 8, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 19 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effectiveness of lesion detection and diagnosis-aiding software (CadAI-B for Breast) during ultrasound (US) examination

Conditions

  • Breast Cancer

Interventions

  • CadAI-B for BreastDevice

    CadAI-B for Breast is designed to assist healthcare professionals in lesion detection and differential diagnosis during breast US examinations.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the LROC CurveTime frame: 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Yonsei University Severance Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.